These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1424192

  • 1. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
    Hassager C, Colwell A, Assiri AM, Eastell R, Russell RG, Christiansen C.
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):45-50. PubMed ID: 1424192
    [Abstract] [Full Text] [Related]

  • 2. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
    Schlemmer A, Hassager C, Delmas PD, Christiansen C.
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
    [Abstract] [Full Text] [Related]

  • 3. Effect of hormone replacement therapy on the bone mass and urinary excretion of pyridinium cross-links.
    Pardini DP, Sabino AT, Meneses AM, Kasamatsu T, Vieira JG.
    Sao Paulo Med J; 2000 Jan 06; 118(1):3-6. PubMed ID: 10685120
    [Abstract] [Full Text] [Related]

  • 4. Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism.
    Nakamura H, Mori T, Genma R, Suzuki Y, Natsume H, Andoh S, Kitahara R, Nagasawa S, Nishiyama K, Yoshimi T.
    Clin Endocrinol (Oxf); 1996 Apr 06; 44(4):447-51. PubMed ID: 8706312
    [Abstract] [Full Text] [Related]

  • 5. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD.
    J Clin Endocrinol Metab; 1991 Feb 06; 72(2):367-73. PubMed ID: 1991806
    [Abstract] [Full Text] [Related]

  • 6. Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
    Reginster JY, Christiansen C, Dequinze B, Deroisy R, Gaspard U, Taquet AN, Franchimont P.
    Calcif Tissue Int; 1993 Jul 06; 53(1):13-6. PubMed ID: 8394191
    [Abstract] [Full Text] [Related]

  • 7. Urinary pyridinoline and deoxypyridinoline excretion in children.
    Shaw NJ, Dutton J, Fraser WD, Smith CS.
    Clin Endocrinol (Oxf); 1995 Jun 06; 42(6):607-12. PubMed ID: 7634501
    [Abstract] [Full Text] [Related]

  • 8. Bone turnover markers and bone density across the menopausal transition.
    Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD.
    J Clin Endocrinol Metab; 1996 Sep 06; 81(9):3366-71. PubMed ID: 8784098
    [Abstract] [Full Text] [Related]

  • 9. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
    Peichl P, Griesmacher A, Pointinger P, Marteau R, Hartl W, Gruber W, Bröll H.
    Calcif Tissue Int; 1998 May 06; 62(5):388-94. PubMed ID: 9541515
    [Abstract] [Full Text] [Related]

  • 10. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults.
    Schlemmer A, Johansen JS, Pedersen SA, Jørgensen JO, Hassager C, Christiansen C.
    Clin Endocrinol (Oxf); 1991 Dec 06; 35(6):471-6. PubMed ID: 1769127
    [Abstract] [Full Text] [Related]

  • 11. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
    Peichl P, Griesmacher A, Müller MM, Marteau R, Kumpan W, Bröll H.
    Gynecol Endocrinol; 2000 Oct 06; 14(5):374-81. PubMed ID: 11109977
    [Abstract] [Full Text] [Related]

  • 12. Biochemical markers in menopausal women.
    Griesmacher A, Peichl P, Pointinger P, Mateau R, Bröll H, Hartl W, Gruber W.
    Scand J Clin Lab Invest Suppl; 1997 Oct 06; 227():64-72. PubMed ID: 9127469
    [Abstract] [Full Text] [Related]

  • 13. A longitudinal study of bone-related biochemical changes at the menopause.
    Nordin BE, WIshart JM, Clifton PM, McArthur R, Scopacasa F, Need AG, Morris HA, O'Loughlin PD, Horowitz M.
    Clin Endocrinol (Oxf); 2004 Jul 06; 61(1):123-30. PubMed ID: 15212654
    [Abstract] [Full Text] [Related]

  • 14. Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography.
    Kollerup G, Thamsborg G, Bhatia H, Sørensen OH.
    Scand J Clin Lab Invest; 1992 Nov 06; 52(7):657-62. PubMed ID: 1455159
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary bone resorption markers in patients with metabolic bone disorders.
    Ohishi T, Kushida K, Takahashi M, Kawana K, Yagi K, Kawakami K, Horiuchi K, Inoue T.
    Bone; 1994 Nov 06; 15(1):15-20. PubMed ID: 8024845
    [Abstract] [Full Text] [Related]

  • 19. Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma.
    Miyamoto KK, McSherry SA, Robins SP, Besterman JM, Mohler JL.
    J Urol; 1994 Apr 06; 151(4):909-13. PubMed ID: 7510346
    [Abstract] [Full Text] [Related]

  • 20. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women.
    Taga M, Shirashu K, Minaguchi H.
    Horm Res; 1998 Apr 06; 49(2):86-90. PubMed ID: 9485177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.